MyFinsight
Home
Blog
About
Cash and cash
equivalents
$41,249K
(120.52%↑ Y/Y)
Accounts receivable, net
$23,266K
(32.93%↑ Y/Y)
Prepaid expenses
$3,635K
(155.81%↑ Y/Y)
Inventory
$2,374K
(7.86%↑ Y/Y)
Other current assets
$1,976K
(104.77%↑ Y/Y)
Non-current accounts
receivable, net
$2,587K
(-21.94%↓ Y/Y)
Other non-current
assets, net of...
$666K
(-13.28%↓ Y/Y)
Total current assets
$72,500K
(77.72%↑ Y/Y)
Total non-current
assets
$3,253K
(-20.31%↓ Y/Y)
Total assets
$75,753K
(68.81%↑ Y/Y)
Total liabilities and
shareholders'...
$75,753K
(68.81%↑ Y/Y)
Total shareholders'
equity/(deficit)
$42,442K
(668.70%↑ Y/Y)
Total liabilities
$33,311K
(-36.36%↓ Y/Y)
Accumulated deficit
-$227,248K
(-1.45%↓ Y/Y)
Common stock, no par
value unlimited...
$193,190K
(32.17%↑ Y/Y)
Total long-term
liabilities
$20,917K
(-52.38%↓ Y/Y)
Total current
liabilities
$12,394K
(47.30%↑ Y/Y)
Additional paid-in capital
$75,257K
(8.87%↑ Y/Y)
Accumulated other
comprehensive income
$1,243K
(0.00%↑ Y/Y)
Contract liability -
long-term
$20,917K
(-14.84%↓ Y/Y)
Accounts payable
$5,516K
(-7.15%↓ Y/Y)
Accrued liabilities
$3,696K
(66.11%↑ Y/Y)
Contract liability -
current
$3,182K
(1183.06%↑ Y/Y)
Back
Back
Balance Sheet
FENNEC PHARMACEUTICALS INC. (FENC)
FENNEC PHARMACEUTICALS INC. (FENC)
source: myfinsight.com